Artificial intelligence for natural product drug discovery
2023 · Nature Reviews Drug Discovery · 342 citations
https://doi.org/10.1038/s41573-023-00774-7
M
Michael W. Mullowney
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
2.0K
Citations
13
h-index
16
i10-index
Michael W. Mullowney is an academic researcher from Duchossois Group (United States). The author has contributed to research in topics: Gut microbiota and health & Microbial Natural Products and Biosynthesis & Genomics and Phylogenetic Studies. The author has an h-index of 13, co-authored 28 publications.
ORCID: 0000-0002-2884-4307Papers by this author
worksA community resource for paired genomic and metabolomic data mining
2021 · Nature Chemical Biology · 126 citations
https://doi.org/10.1038/s41589-020-00724-z
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure
2022 · Nature Communications · 70 citations
https://doi.org/10.1038/s41467-022-34260-2
Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease
2025 · Gastro Hep Advances · 3 citations
https://doi.org/10.1016/j.gastha.2025.100695
Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality
2025 · Science Advances · 2 citations
https://doi.org/10.1126/sciadv.adt1466
IDBac: an open-access web platform to identify bacteria and analyze relationships in culture collections using MALDI-TOF mass spectrometry
2025 · bioRxiv (Cold Spring Harbor Laboratory) · 0 citations
https://doi.org/10.1101/2025.10.15.682631
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat